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BACKGROUND
Papillary tumors of the temporal bone are very rare but 
aggressive neoplasms. In the past, a middle-ear origin was 
presumed. Only recently convincing evidence exists that 
these tumors in fact arise from the endolymphatic sac.
METHODS
We present a case of an endolymphatic sac tumor (ELST) 
with detailed clinical, imaging, operative, and pathologic 
data. The literature on this rare tumor type is reviewed,
RESULTS
This 63-year-old woman had a progressive mass lesion in 
the temporal bone for a period of more than 35 years, 
resulting in unilateral fifth to eleventh cranial nerve palsy, 
progressive ataxia, and a pyramidal and pseudobulbar 
syndrome. Computerized tomography (CT) and magnetic 
resonance imaging (MRI) showed a tumor invading the 
pars squamosa and petrosa of the temporal bone, and 
extending into the middle and posterior fossa, Angiogra­
phy demonstrated a hypervascular tumor mass. The pa­
tient underwent surgery, with nonradical removal of a 
tumor. Histologic examination demonstrated a papillary 
ELST, A search through the literature revealed 36 pa­
tients with ELST, based on convincing anatomic and his­
tologic considerations.
CON CLU SION S
It is important to make a distinction between ELST and 
the more benign middle-ear adenomas, since this leads to 
a different treatment and prognosis. ELST frequently in­
vades the surrounding structures and extends intracra- 
nially. The treatment of choice is a radical resection, 
although complete resection is impossible in most of the 
cases. The value of adjunctive radiation therapy remains 
controversial. © 1997 by Elsevier Science Inc.
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P apillary tumors of the temporal bone are very 
rare but aggressive neoplasms. The site of or­
igin and malignant potential of these tumors has 
been controversial in the past. The lesions were 
usually identified as middle-ear adenomas [14,21], 
adenomatous tumors [2,3,18], or adenocarcinomas
[1,5,7,8,10,11,22,26-28]. It was not until 1989 that
Heffner proposed the endolymphatic sac, recog­
nized by Hassard and Boudreau as a source of neo­
plasms in 1984 [12], as the true site of origin [13]. In 
recent years, modern imaging methods have helped 
to pinpoint papillary tumors of the temporal bone 
to the endolymphatic sac region, thereby solving 
previously unexplained cases of papillary neo­
plasms. The term endolymphatic sac tumor (ELST) 
was coined for this clinicopathologic entity [15].
We present a case of ELST with a follow-up of 
over 35 years. The literature on this rare tumor type 
is reviewed.
C a s e  R e p o r t
C L IN IC A L  HISTORY
This 63-year-old Caucasian woman was admitted to 
-the hospital in 1977 with a 20-year history of slowly 
progressive, left-sided hearing loss and recurrent 
episodes of ipsilateral facial weakness, imbalance, 
and ataxia. During surgery, a firm, solid tumor was 
found in the left cerebellopontine angle. Due to 
extensive bony infiltration, removal was incom-
© 1997 by Elsevier Science Inc. 
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D  Three-dimensional CT (transverse section) showing the expansive and destructive nature of papillary ELST, 
extending intracranially and extracranially
plete. Pathologic examination showed a possible 
multilocular epidermoid cyst.
in 1979, progressive neurologic deterioration oc­
curred. Imaging studies demonstrated a recurrent 
mass lesion. The patient underwent surgery, with 
non-radical removal of a tumor that consisted of 
several cystic portions and one solid component. 
On pathologic examination, it was reported to be a 
hamartomatous multilocular cyst, concurring with 
the diagnosis in 1977.
In 1991, the patient returned with complaints of 
episodes of headache and increased ataxia, A left­
sided, temporo-occipital, solid swelling was noted. 
Imaging studies showed a highly vascular tumor, 
extending intracranially and extracranially and in­
filtrating the left pars petrosa and squamosa of the 
temporal, as well as the parietal bone. Again, the 
tumor could only be partially removed. The patho­
logic diagnosis now was a tumor of Rathke’s cleft 
cyst. The patient was referred again for evaluation 
in 1993. At the left side of the skull a temporo- 
occipital, solid, pulsatile swelling with a diameter of 
7-10 cm was found. Neurologic examination re­
vealed a complete paralysis of the fifth to eleventh 
cranial nerves on the left side and ataxia. Three- 
dimensional computed tomography (CT) showed a 
heterogenous mass lesion with cystic components, 
expanding both intracranially and extracranially 
(Figure 1). Arteriography demonstrated a hypervas-
cular tumor mass supplied by both the left internal 
and external carotid and the left vertebral artery 
(Figure 2). During admission, the neurologic situa­
tion suddenly deteriorated. The patient became ap­
athetic and drowsy and showed a pyramidal and 
pseudobulbar syndrome. Magnetic resonance imag­
ing (MRI) demonstrated compression of the brain­
stem and a midline shift of the left hemisphere 
without tumor infiltration (Figure 3).
Therefore, palliative surgery was planned, with 
preoperative embolization of the left external ca­
rotid artery. The supratentorial mass was removed 
completely, the brainstem was decompressed in- 
fratentorially. The tumor did not seem to infiltrate 
into adjacent tissue. Removal of tumor tissue from 
the petrous bone was partially performed. The op­
eration was terminated because of excessive bleed­
ing and the long duration, leaving residual tumor 
behind in the petrous bone, the skull base of the 
middle fossa, and the extracranial region around 
the zygoma. Postoperatively, the patient recovered 
gradually, the remaining symptoms being a unilat­
eral fifth to eleventh cranial nerve palsy and a py­
ramidal syndrome (MRC 4) of the right arm.
Since then, the patient is in a neurologically sta­
ble condition. A follow-up CT scan of the brain 
demonstrated only a slight increase of the intracra­
nial tumor mass, but extensive extracranial expan­
sion in the region of thezygoma, the maxilla, and
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Angiography (AP) demonstrating the tumor blush 
on the left side, fed by both the left internal and 
external carotid and the left vertebral artery.
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the lateral orbita. For this reason additional cos­
metic surgery was performed (Figure 4).
H IS TO P A TH O LO G Y
Previous diagnoses of the resected tumor tissue 
had been epidermoid cyst, hamartomatous tumor, 
and Rathke’s cleft tumor. Revision of the histologic 
material, however, showed an ELST from the first 
operation. This was confirmed by the histologic 
examination of the latest tumor specimens: the tu­
mor consisted of cystic spaces lined with papillary 
formations within trabecular bone. The papillary 
formations were covered with a single layer of 
cuboid to cylindrical cells, with basally placed hy- 
perchromatic oval nuclei, with only slight pleiomor- 
phism. Mitotic figures were only scarcely found. 
The periodic acid-Schiff (PAS) stain showed diffuse 
positivity within the cytoplasm of many tumor cells, 
as well as for cytokeratin. SI00 immunostaining was 
very weakly positive. The stroma was thin, with 
many small capillaries. Traces of previous hemor­
rhage were present. Necrosis was seen in the vicin­
ity of larger blood vessels filled with the emboliza­
tion material (Figure 5).
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MRI scan showing compression of the brainstem 
and a midline shift of the left hemisphere, without 
tumor infiltration.
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D i s c u s s i o n
The confusing terminology of adenomatous tumors 
of the temporal bone is due to controversy about 
their origin, their histology, and their clinical be-
Contrast-enhanced CT scan demonstrating the pro­
cess at the skull base after additional cosmetic 
surgery.
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5 Light microscopy (haematotoxylin-eosin stain, 100 X ) showing papillary structures of ELST.
havior: most of the tumors follow a benign clinical 
course, but some behave more aggressively and 
invade locally, frequently with intracranial exten­
sion [2-5,9,14,21,22,25,27]. Several authors noted 
that the more aggressive neoplasms were histolog-
sac as a possible source of neoplasms [12]. In 1989, 
Heffner reviewed the clinical and histologic features 
of 20 cases of papillary-cystic temporal bone neo­
plasm, concluded that these tumors were all low- 
grade adenocarcinoma, and postulated the en­
dolymphatic sac as the true site of origin [13].
Based on surgical discoveries of early tumors and 
modern imaging methods (CT and MRI), the evi­
dence is now convincingly strong for relating the 
origin of this tumor type to the endolymphatic sac. 
In 1993, Li et al. proposed a reclassification of these 
neoplasms as ELST [15-17,19],
Most of the reported ELSTs are sporadic, but 
several papillary tumors of the endolymphatic sac, 
sometimes bilateral, have been described in pa­
tients with von Hippel-Lindau disease [6,23,24], The 
extent of the association between von Hippel- 
Lindau disease and ELST is still unclear. Alertness 
on the part of radiologists reviewing images of 
these patients, may lead to early detection and 
early resection [16].
C L IN IC A L  FE A TU R E S
ically characterized by a papillary architecture, dis- Thirty-seven patients with ELST have been re-
tinguishing them from less aggressive adenomas, ported in the literature so far, including our patient
Cytologically, these papillary tumors were com- (Table 1). ELSTs occur more frequently in women
posed of uniform, cuboidal cells with clear to eo- (23 women and 14 men), The patients with ELST
sinophilic cytoplasm [3,9,14,21]. range from 15-71 years (average = 41 years) in age
A middle-ear origin was presumed and in 1988, [9,13,15,19].
Gaffey et al. coined the term aggressive papillary The most common clinical signs are unilateral
middle-ear tumor (APMET) for this clinicopatho- hearing loss, facial weakness, otitis, tinnitus, and
logic entity [9]. In 1990, Benecke et al. presented vertigo. On clinical examination at the time of pre-
five new cases of APMET, reconfirming the distinc- sentation, very often a blue or red discoloration is
tive histopathologic and clinical pattern [3]. seen behind an intact tympanic membrane and usu-
Evidence now exists, however, that papillary tu- ally the facial nerve is invaded by the tumor mass
mors of the temporal bone do not, in fact, arise from [9,13,15,19].
the middle-ear mucosa. In 1984, Hassard and Bou- Radiologically the tumors appear to be centered
dreau were the first to describe the endolymphatic between the sigmoid sinus and the internal audi-
Review of the Literature of Papillary ELSTs
Author Number
AGE (MEDIAN 
± RANGE) 
IN YEARS
M/F
Ratio
Described structure
OF NEOPLASM Stated D iagnosis
Hassard et al. 1 34 o/i Papillary Adenoma of the endolymphatic
(1984) Cystic sac
Glandular
Gaffey et al. 10 41 (26-55) 3/7 Papillary Aggressive papillary middle ear
(1988) Occasional nests of cells tumor (APMET)
Heffner 20 42 (15-71) 10/10 Papillary cystic glandular Low-grade adenocarcinoma of
(1989) endolymphatic sac, origin
Li et al. 6 48 (18-57) 1/5 Papillary solid nests ELST
(1993) Glandular
Meyer et al. 1 24 1/0 Papillary solid nests Invasive papillary cystadenoma
(1993) of endolymphatic sac origin
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tory canal along the posterior petrosal plate, in the 
region of the vestibular aqueduct. Bone erosion 
towards the vestibule of the labyrinth may be seen. 
The mastoid air cells remain pneumatized, distin­
guishing the lesion from neoplasms arising from the 
middle ear [15]. Angiography often demonstrates 
vascular or hypervascular masses with intracranial 
as well as extracranial blood supply [9,13,19]. Al­
most all cases of ELST show intracranial extension. 
Invasion of the brain, however, has only been re­
ported in a single case [9,10]. Distant metastases 
have never been identified.
The preoperative diagnosis of ELST can be very 
difficult to make. Due to a similarity in clinical fea­
tures, ELSTs are most commonly confused with 
paragangliomas. Paragangliomas also produce 
hearing loss of long duration, often present as a red 
mass behind an intact tympanic membrane, and 
show radiologically a hypervascular mass in the 
temporal bone with extensive bone destruction
[22]. The differential diagnosis of ELST also includes 
ceruminous gland tumors, papillary choroid plexus 
tumors, meningiomas, benign adenomatous tu­
mors, and metastatic lesions (e.g., thyroid, bron­
chus) [15].
TH ER A PY A N D  FOLLOW -UP
The review of Heffner shows a 90% cure rate for 
total tumor removal without radiation [13]. Due to 
the aggressive growth pattern of ELST, however, it 
may be extremely difficult to remove all tumor tis­
sue during an operation. The local invasiveness and 
hypervascular nature lead to profuse bleeding dur­
ing surgery and are complicating factors when at­
tempting a radical removal. It remains controversial 
as to whether this lesion should be considered ma­
lignant and if radiation therapy has any role in the 
treatment of a macroscopically resectable ELST
[13,15].
In the case of the diagnosis of ELST, the chance of 
long-term cure is small. The exact median survival 
of ELST is difficult to determine from the data in the 
literature. Follow-up data on 33 patients from 1 
month-21 years (average: 58 months) demon­
strated that 25 patients (76%) were without evi­
dence of tumor growth. Four patients (12%) died 
and four patients (12%) were still alive after one or 
more local recurrences [9,12,13,15].
The lack of tumor recurrence or progression in 25 
patients may possibly be attributed to the ex­
tremely slow growth rate of the tumor, in combina­
tion with a short follow-up period. Two of the three 
patients with a follow-up period of more than 10 
years, including our own patient with an 18-year 
follow-up, showed three local recurrences. A long­
term follow-up, with annual imaging, is therefore 
recommended for a period of more than 10 years.
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A l c o h o l  w a s  t h e  t h i r d  m o s t  i m p o r t a n t  r o o t
CAUSE OF DEATH IDENTIFIED, TAKING 100,000 
LIVES [IN 1990]. AN ESTIMATED 18 MILLION PEOPLE 
IN THE UNITED STATES SUFFER FROM ALCOHOL DE­
PENDENCE, AND 76 MILLION ARE AFFECTED BY AL­
COHOL ABUSE AT SOME TIME DURING THEIR LIVES. 
ALCOHOL ABUSE IS RESPONSIBLE FOR AT LEAST 3% 
OF ALL CANCER DEATHS, 60% OF ALL CIRRHOSIS 
DEATHS, 40% OF ALL MOTOR VEHICLE FATALITIES, 
AND 1 6% OF ALL OTHER INJURIES.
— R. G r a n t  S t e e n  
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‘T h e  F u t u r is t ,” Ma r c h -Ap r il  1 9 9 7
